Induction of Cellular Senescence by Insulin-like Growth Factor Binding Protein-5 through a p53-dependent Mechanism
Open accessThe DOI matches its Crossref record; 75 of the 76 references it cites were found in a registry or an index.
Abstract
The insulin-like growth factor (IGF) signaling pathway plays a crucial role in the regulation of cell growth, differentiation, apoptosis, and aging. IGF-binding proteins (IGFBPs) are important members of the IGF axis. IGFBP-5 is up-regulated during cellular senescence in human dermal fibroblasts and endothelial cells, but the function of IGFBP-5 in cellular senescence is unknown. Here we show that IGFBP-5 plays important roles in the regulation of cellular senescence. Knockdown of IGFBP-5 in old human umbilical endothelial cells (HUVECs) with IGFBP-5 micro-RNA lentivirus caused partial reduction of a variety of senescent phenotypes, such as changes in cell morphology, increases in cell proliferation, and decreases in senescence-associated β-galactosidase (SA-β-gal) staining. In addition, treatment with IGFBP-5 protein or up-regulation of IGFBP-5 in young cells accelerates cellular senescence, as confirmed by cell proliferation and SA-β-gal staining. Premature senescence induced by IGFBP-5 up-regulation in young cells was rescued by knockdown of p53, but not by knockdown of p16. Furthermore, atherosclerotic arteries exhibited strong IGFBP-5–positive staining along intimal plaques. These results suggest that IGFBP-5 plays a role in the regulation of cellular senescence via a p53-dependent pathway and in aging-associated vascular diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“STAT3 was similarly described to be essential for both the early ROS increase, as well as the later senescence-associated-β-galactosidase activity, through STAT3-regulated soluble factor insulin-like growth factor binding protein 5 in both human fibroblasts (Udono et al., 2012) and vascular endothelial cells (Kim et al., 2007).”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Kim et al., 2007
In the citing paper
“In turn, metabolic and signaling changes seen in diabetes, such as high circulating glucose, altered lipid metabolism, and growth hormone axis perturbations, can promote senescent cell formation.”
From Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity (2015) · cites this paper as [41]
In the citing paper
“The ability of multiple individual components of this pathway to induce senescence has been recently shown, including growth hormone, IGF-1, and IGF binding protein 5 (IGFBP5) (27,28,41).”
From Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity (2015) · cites this paper as [41]
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508 · cited 1×
“Normal somatic cells cultured in vitro have a limited ability to divide and then enter a state of irreversible proliferative arrest, termed replicative senescence ( Hayflick and Moorhead, 1961 ).”
BackgroundA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“SA--gal activity in cells was measured as described previously (Dimri et al., 1995).”
MethodOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“such as Ras (Serrano et al., 1997) or Raf (Zhu et al.”
BackgroundSenescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379 · cited 1×
“Accumulating evidence implicates the tumor suppressors, p53, p16, and Rb, as the common major effectors of cellular senescence in normal somatic cells (Beausejour et al., 2003; Campisi, 2005).”
BackgroundIGF-1 receptor regulates lifespan and resistance to oxidative stress in mice
Holzenberger, M., Dupont, J., Ducos, B., Leneuve, P., Géloën, A., Even, P. C., Cervera, P., & Le Bouc, Y. (2003) · Nature · doi:10.1038/nature01298 · Cited by 2,109 · cited 1×
“, 2003) or IGF1R (Holzenberger et al., 2003) increased life span.”
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Firth, S. M., & Baxter, R. C. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0033 · Cited by 1,750 · cited 2×
“The IGFBPs comprise a family of six proteins, IGFBP-1 to -6, that bind to IGFs with high affinity (Firth and Baxter, 2002).”
Backgroundp53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459
Reversal of human cellular senescence: roles of the p53 and p16 pathways
Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg417 · Cited by 1,457 · cited 1×
“Accumulating evidence implicates the tumor suppressors, p53, p16, and Rb, as the common major effectors of cellular senescence in normal somatic cells (Beausejour et al., 2003; Campisi, 2005).”
BackgroundThe signals and pathways activating cellular senescence
Ben-Porath, I., & Weinberg, R. A. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.013 · Cited by 1,046 · cited 2×
“Accumulating evidence suggests that p53 and p16/Rb tumor suppressor pathways are key regulators of the senescence response (Ferbeyre et al., 2002; Ben-Porath and Weinberg, 2005).”
BackgroundInduction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869 · cited 2×
“, 1997), and PAI-1 and IGFBP-3 are transcriptional targets of p53 (Buckbinder et al., 1995; Zhao et al., 2000).”
Background
Research works printed but not linked: 5
- Campbell P. G., 1997, Am. J. Physiol, 273, E1005
- Gui Y., 2001, J. Clin. Endocrinol. Metab, 86, 2104
- Nam T. J., 1997, Endocrinology, 138, 2972, 10.1210/endo.138.7.5230 · doi:10.1210/endo.138.7.5230 · Paper page
- Pekonen F., 1992, Cancer Res, 52, 5204
- Valentinis B., 1995, Mol. Endocrinol, 9, 361
Cited by
Items 101–200 of 200
A global genomic view of MIF knockdown-mediated cell cycle arrest
Liu, L., Ji, C., Chen, J., Li, Y., Fu, X., Xie, Y., Gu, S., & Mao, Y. (2008) · Cell Cycle · doi:10.4161/cc.7.11.6011 · Cited by 30
Gwon, M., Cho, J. H., & Kim, J.-R. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.10.012 · Cited by 30
“When cells were exposed to adriamycin, which induces premature senescence [29], the level of MCAK/Kif2C protein declined in a time-dependent manner (Fig.”
BackgroundSelf-citationHeo, J.-I., Cho, J. H., & Kim, J. (2013) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls257 · Cited by 37
“Furthermore, because cytotoxic agents such as adriamycin induce premature senescence (27), we also measured the expression levels of HJURP in HDFs and HUVECs treated with adriamycin (Figure 1C).”
BackgroundSelf-citationChua, M. W. Y., Lin, M. Z., Martin, J. L., & Baxter, R. C. (2015) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-015-0262-1 · Cited by 27
Alessio, N., Aprile, D., Peluso, G., Mazzone, V., Patrone, D., Bernardo, G. D., & Galderisi, U. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01469-1 · Cited by 29
“Notably, previous findings reveal that IGFBPs, when introduced either to cell culture medium or living organisms, can trigger senescence at both the cellular and organismal levels [11, 16, 47].”
BackgroundWu, J., Wang, C., Xiong, M., Wu, Y., Yuan, J., Ding, M., Li, J., & Shi, Z.-C. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477873 · Cited by 25
MicroRNA-mediated regulation of extracellular matrix formation modulates somatic cell reprogramming
Li, Z., Dang, J. W., Chang, K., & Rana, T. M. (2014) · RNA · doi:10.1261/rna.043745.113 · Cited by 24
“It was recently shown that IGFBP5 overexpression induces cell senescence in a p53-dependent manner (Kim et al. 2007).”
Kundu, D., Kennedy, L. L., Zhou, T., Ekser, B., Meadows, V., Sybenga, A. B., Kyritsi, K., Chen, L., Ceci, L., Wu, N., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000307 · Cited by 27
“For example, a specific IGF binding protein, IGFBP5, induces human umbilical endothelial cell senescence,[45] demonstrating a feedback mechanism between IGF-1 and cellular senescence.”
BackgroundKenny, T. C., Schmidt, H., Adelson, K. B., Hoshida, Y., Koh, A. P., Shah, N., Mandeli, J., Ting, J., & Germain, D. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0342 · Cited by 29
“senescence is reported to be p53-dependent (21).”
Senescence and Type 2 Diabetic Cardiomyopathy: How Young Can You Die of Old Age?
Henson, S. M., & Aksentijević, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.716517 · Cited by 25
“Components of this pathway such as growth hormone, IGF1 and IGF5 binding protein (IGFBP5) have all been shown to trigger senescence (Kim et al., 2007; Stout et al., 2014; Tran et al., 2014).”
BackgroundNojima, I., Hosoda, R., Toda, Y., Saito, Y., Ueda, N., Horimoto, K., Iwahara, N., Horio, Y., & Kuno, A. (2022) · Aging · doi:10.18632/aging.203999 · Cited by 23
“As previously reported [33], IGFBP5 expression level was upregulated in senescent HUVECs (Supplementary Figure 7D).”
BackgroundInfluentialYang, H. H., Kim, C., Jung, B., Kim, K. S., & Kim, J.-R. (2011) · Biogerontology · doi:10.1007/s10522-010-9318-z · Cited by 22
“Additionally, IGFBP5 expression was reported to be substantially up-regulated during replicative senescence in human dermal fibroblasts (HDFs) (Yoon et al. 2004) and endothelial cells (Kim et al. 2007a).”
BackgroundMethodInfluentialSelf-citationLeung, K.-P., Qu, Y.-H., Qiao, D., Xie, W., Li, D., XU, J.-T., Wang, H., & Yue, X. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2572 · Cited by 20
“Silencing of IGFBP5 expression allowed examination of its distinct cellular, physiological and patho-physiological functions (38,40).”
Stress-induced cellular senescence contributes to chronic inflammation and cancer progression.
KOBASHIGAWA, S., M. SAKAGUCHI, Y., MASUNAGA, S., & MORI, E. (2019) · Thermal Medicine · doi:10.3191/thermalmed.35.41 · Cited by 18
Sobeai, H. M. A., Alohaydib, M. H., Alhoshani, A., Alhazzani, K., Almutairi, M. M., Saleh, T., Gewirtz, D. A., & Alotiabi, M. R. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.12.004 · Cited by 20
Zhang, H., Zhang, G., Xiao, M., Cui, S., Jin, C., Yang, H. J., Wu, S., & Lu, X. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03161-1 · Cited by 25
“On the other hand, IGFBP5 was shown to induce the phosphorylation modification of p53 at ser 15 to enhance its stability and transcriptional activity, thereby executing anti-tumor functions in a p53-dependent manner [35].”
BackgroundVeraldi, K. L., & Feghali-Bostwick, C. A. (2012) · The Open Rheumatology Journal · doi:10.2174/1874312901206010140 · Cited by 21
“The IGFBPs regulate multiple steps of the fibrotic cascade and thus hold great promise as druggable targets in the continuing quest to cure fibrosis.”
Addressing osteoblast senescence: Molecular pathways and the frontier of anti‐ageing treatments
Zhang, Z., Liu, P., Song, Y., Ma, L., Xu, Y., Lei, J., Tong, B., Zhu, D., Liang, H., Wang, H., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70417 · Cited by 25
Talin-1 interaction network promotes hepatocellular carcinoma progression
Chen, P., Zheng, X., Zhou, Y., Xu, Y., Zhu, L., & Qian, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.14674 · Cited by 17
“Endothelin-1 (EDN1) and insulin-like growth factor binding protein 5 (IGFBP5) are well-known cell cycle regulators in the p53 network, and they are reported to be highly expressed in HCC [15, 16].”
BackgroundPan, W., Ding, Q., Wang, Y., Wang, D., Lu, Y., Yang, W., Cai, Z., Cheng, X.-D., Zhang, W., & Chen, Y. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2017.12.070 · Cited by 17
Lee, D. H., Kim, J. E., & Kang, Y. J. (2013) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2013.17.2.157 · Cited by 17
“In a recent data, they showed that IGFBP-5 immunoreactivity was increased in old human arteries compared with young human arteries and was also strong in atherosclerotic plaques [17].”
BackgroundSelf-citationMechanisms of endothelial senescence and vascular aging
Qiao, L., Qian, Z., Huang, Y., Yang, X. F., Yang, J., Xiao, N., Liang, G., Zhang, H., Fu, Y., Yan, L., et al. (2025) · Biogerontology · doi:10.1007/s10522-025-10279-y · Cited by 27
“IGF-binding protein 3 (IGFBP3) promotes human umbilical vein endothelial cells senescence (Kim et al. 2007a).”
InfluentialNili, M., Mukherjee, A., Shinde, U. P., David, L. L., & Rotwein, P. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.285528 · Cited by 17
Insulin-like Growth Factor-binding Protein-5-induced Laminin γ1 Transcription Requires Filamin A
Abrass, C. K., & Hansen, K. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.061754 · Cited by 16
Wuestefeld, A., Iakovleva, V., Yap, S. X. L., Ong, A. B. L., Huang, D. Q., Shuen, T. W. H., Toh, H. C., Dan, Y. Y., Zender, L., & Wüestefeld, T. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1477 · Cited by 18
Pan, Y., Gu, Z., Lyu, Y., Yang, Y., Chung, M., Pan, X., & Cai, S. (2022) · Rejuvenation Research · doi:10.1089/rej.2022.0021 · Cited by 19
He, M., & Borlak, J. T. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00373-5 · Cited by 15
“One study reported induction of cellular senescence by Igfbp5 through a p53-dependent mechanism [144].”
BackgroundYao, B., Zhang, Y., Wu, Q., Yao, H., Peng, L., Jiang, Z., Yang, L., & Yuan, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-79607-5 · Cited by 16
Saccà, S. C., Vernazza, S., Iorio, E. L., Tirendi, S., Bassi, A. M., Gandolfi, S., & Izzotti, A. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.06.003 · Cited by 17
Mano, S. S., Uto, K., & Ebara, M. (2017) · Theranostics · doi:10.7150/thno.20582 · Cited by 15
“IGFBP5 induces cellular senescence by a p53-dependent pathway [44].”
BackgroundGiovos, G., Yavropoulou, M. P., & Yovos, J. G. (2019) · HORMONES · doi:10.1007/s42000-019-00132-6 · Cited by 17
“Similarly, IGFBP5 has been found to increase during senescence of endothelial cells and fibroblasts and to induce senescence via a p53-dependent mechanism [51].”
Backgroundcfa-miR-143 Promotes Apoptosis via the p53 Pathway in Canine Influenza Virus H3N2-Infected Cells
Zhou, P., Tu, L., Lin, X., Hao, X., Zheng, Q., Zeng, W., Zhang, X., Zheng, Y., Wang, L., & Li, S. (2017) · Viruses · doi:10.3390/v9120360 · Cited by 14
“Igfbp5, the target gene of cfa-mir-143, plays roles in the regulation of cellular senescence via a p53-dependent pathway and in aging-associated vascular diseases [52].”
BackgroundProteomic Analysis Reveals Anti‐Fibrotic Effects of Blue Light Photobiomodulation on Fibroblasts
Chang, L., Fan, S. M., Liao, Y., Wang, W., Chen, Y., & Lin, S. (2019) · Lasers in Surgery and Medicine · doi:10.1002/lsm.23137 · Cited by 15
Yang, H. H., Zhang, H., Son, J., & Kim, J. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0577-8 · Cited by 13
“HUVECs in PD[ 50 were used as old cells under replicative senescence (Yoon et al. 2004; Kim et al. 2007).”
BackgroundMethodSelf-citationGonzález‐Hedström, D., Priego, T., López‐Calderón, A., Amor, S., de la Fuente‐Fernández, M., Inarejos-García, A. M., García-Villalón, Á. L., Martín, A. I., & Granado, M. (2020) · Nutrients · doi:10.3390/nu13010044 · Cited by 14
“with the process of senescence [47] and plays a key role in apoptosis by interfering with the IGF signaling pathway [10].”
BackgroundCritical Role of Cathepsin L/V in Regulating Endothelial Cell Senescence
Li, C., Liu, Z., Chen, M., Zhang, L., Shi, R., & Zhong, H. (2022) · Biology · doi:10.3390/biology12010042 · Cited by 12
Mishra, M., Kim, H.-H., Youm, Y.-H., Gonzalez-Hurtado, E., Zaitsev, K., Dlugos, T., Shchukina, I., Gliniak, C., Ravussin, E., Mohanty, S., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01107-0 · Cited by 10
“IGFBP2 and IGFBP5 may impact mechanisms of aging by lowering the insulin growth factor 1 (IGF-1) bioavailability and are related to reduced mortality 29 and cellular senescence 30 , respectively.”
de Celis, M. F. R., & Bonner‐Weir, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217729 · Cited by 13
“IGFBP5 has been suggested as a potential target for vascular diseases since atherosclerotic arteries showed strong staining for IGFBP5 (75).”
BackgroundLee, S. S., Halawani, A. A., Teo, J. D., Weiss, A. S., & Yeo, G. C. (2024) · Advanced Science · doi:10.1002/advs.202402168 · Cited by 12
The Chromatin Remodeling ComponentArid1aIs a Suppressor of Spontaneous Mammary Tumors in Mice
Kartha, N., Shen, L., Maskin, C. R., Wallace, M. D., & Schimenti, J. C. (2016) · Genetics · doi:10.1534/genetics.115.184879 · Cited by 12
“IGFBP5 was found to activate cellular senescence through a TRP53-dependent mechanism in human endothelial cells (Kim et al. 2007).”
BackgroundGamma Tocotrienol Protects Mice From Targeted Thoracic Radiation Injury
Kumar, V. P., Stone, S., Biswas, S., Sharma, N., & Ghosh, S. P. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.587970 · Cited by 10
“Over expression of Insulin like Growth Factor Binding Protein 5 (IGFBP-5) has been correlated with cellular senescence (Kim et al., 2007) and also identified as profibrotic factor which could be an important target for antifibrotic therapies in the case of Idiopathic Pulmonary Fibrosis (Sureshbabu et al.”
BackgroundAlterations of receptors and insulin-like growth factor binding proteins in senescent cells
Matuszewska, J., Krawiec, A., Radziemski, A., Uruski, P., Tykarski, A., Mikuła‐Pietrasik, J., & Książek, K. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151438 · Cited by 8
Insulin-like Growth Factor System and Aging
Li, P., Sun, X. F., Cai, G.-Y., & Chen, X. M. (2017) · Journal of Aging Science · doi:10.4172/2329-8847.1000171 · Cited by 8
“This indicates that IGFBP5 has an important role in the regulation of cell aging and aging associated with vascular diseases through a p53 dependent pathway [42].”
BackgroundBianchi, A., Lipchick, B. C., & Nikiforov, M. A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6670-7_1 · Cited by 10
“implicated in the establishment/support of the senescent phenotype; these include the matricellular protein CCN1 (also known as CYR61) (20) and other ECM-related components such as integrin β1 (21) and plasminogen-inhibitor-1 (PAI-1) (22), and secreted factors such as insulin-like growth factor binding proteins (IGFBP…”
BackgroundThe IGF-1 senescence switch: a biphasic model for SASP-driven aging and precision senomodulation
Manni, E., Al‐kuraishy, H. M., Hussain, N. R., Abdelaziz, A. M., & Batiha, G. E. (2026) · Cytokine · doi:10.1016/j.cyto.2026.157143 · Cited by 9
Yao, T., Wang, L., Ding, Z., & Yin, Z. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24134 · Cited by 7
Palmer, A. K., Jensen, M. D., Tchkonia, T., & Kirkland, J. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00009-2 · Cited by 9
Mendel, O. I., Luchikhina, L. V., & Mendel, W. (2015) · Advances in Gerontology · doi:10.1134/s2079057015040165 · Cited by 9
Li, L., Wang, H., Yu, D., Wang, Y., Zhao, Y., Yang, H., Cao, Y., & Cao, Y. (2022) · Cell and Tissue Banking · doi:10.1007/s10561-022-10030-8 · Cited by 7
“IGFBP5 is up-regulated in premature and replicative senescence and plays critical role in controlling cell senescence through P53 in umbilical vein endothelial cells (Kim et al. 2007; Rombouts et al. 2014).”
BackgroundDuan, Y., Chen, Y., He, Y., Gong, R., & Xia, Z. (2024) · Scientific Reports · doi:10.1038/s41598-024-69098-9 · Cited by 5
Meeting Report: International Symposium on the Genetics of Aging and Life History II
Artan, M., Hwang, A. B., Lee, S., & Nam, H. G. (2015) · Aging · doi:10.18632/aging.100762 · Cited by 4
“Jae-Ryong Kim (Yeungnam University, South Korea) presented his work showing that insulin-like growth factor binding proteins (IGFBP3 and IGFBP-5) and interferon gamma (IFN-γ) accelerate cellular senescence through a p53-dependent DNA damage signaling pathway [28-30].”
Mohapatra, S. K., Singh, S., Kumar, S., Dang, A. K., Datta, T. K., Das, S. K., Mohanty, T. K., Kaushik, J. K., & Mohanty, A. K. (2014) · animal · doi:10.1017/s1751731114002985 · Cited by 4
Shi, J., Zhang, M., Hu, Y., Liu, J., Li, K., Sun, X., Chen, S., Liu, J., Ye, L., Fan, J., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106909 · Cited by 4
“…differential expression (with an FPKM value greater than one in at least one group), we found that such as IGFBP2, had been reported to be related to transcriptional activation and aging (Li et al., 2020; Kim et al., 2007), exhibit higher level of expression specificity in MCI patients (Fig.”
IGFBP5 Promotes Atherosclerosis in APOE−/− Mice Through Phenotypic Transformation of VSMCs
Xiang, A., Guan, H., Su, P., Zhang, L., Chen, X., & Yu, Q. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47070555 · Cited by 3
“Notably, IGFBP5 expression is amplified within atherosclerotic lesions, wherein copious quantities of the protein are observed in intimate association with the extracellular matrix enveloping these plaques [17,18].”
An, Y., Zhao, W., Zuo, L., Fan, J., Chen, Z., Jin, X., Du, P., Han, P., Zhao, W., & Yu, D. (2024) · Abdominal Radiology · doi:10.1007/s00261-024-04608-x · Cited by 3
“High insulin levels increase free insulin-like growth factor 1 (IGF-1), which binds to and promotes tumor induction through mechanisms such as enhancing cell proliferation, differen - tiation, and vascularization [50].”
Screening of Plants with Inhibitory Activity on Cellular Senescence
Lee, S., Kim, J.-R., Noh, H.-J., Kim, G.-S., Lee, J., Choi, J., Lee, D.-Y., & Kim, S.-Y. (2014) · 한국자원식물학회지 · doi:10.7732/kjpr.2014.27.6.601 · Cited by 3
Self-citationImportant miRs of Pathways in Different Tumor Types
Wuchty, S., Arjona, D., & Bauer, P. O. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002883 · Cited by 2
Choi, J., Jang, G. Y., Lee, J.-H., Chung, H. Y., Noh, H.-J., Kim, G., & Lee, S. (2021) · Processes · doi:10.3390/pr9050801 · Cited by 2
“HDFs at a PD < 35 were used for doxorubicin-induced cellular senescence, while HDFs at a PD > 75 were used to represent old cells under replicative senescence [14,15].”
MethodMadonna, R. (2022) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2021.34 · Cited by 2
Insulin Resistance and the Prognosis in Diffuse Large B-cell Lymphoma
Zhou, W., Hou, X., Liu, L., Gao, Q., Feng, L., & Wang, Y. (2023) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2023.04.411 · Cited by 3
Bae, Y., Sung, H., & Kim, J.-R. (2017) · Journal of Visualized Experiments · doi:10.3791/55035 · Cited by 2
Self-citationIGFBP2 protects against pulmonary fibrosis through inhibiting P21-mediated senescencePreprint
Chin, C., Lee, J., Ravichandran, R., Fleming, T. P., Wheatcroft, S. B., Kearney, M. T., Bremner, R. M., Mohanakumar, T., Flint, D. J., & Sureshbabu, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.21.427684 · Cited by 2
Zeng, S., Guo, C., Pratte, K., Luo, G., Bowler, R. P., & Arjomandi, M. (2026) · Annals of the American Thoracic Society · doi:10.1093/annalsats/aaoag051 · Cited by 2
miR-203 improves pressure overload-induced heart failure by targeting the IGFBP5/PI3K/AKT axis
Tang, P., Xu, R., Wang, S., Zhang, W.-Y., Dong, X., Yao, L.-N., Kong, L., Mao, C., Bao, Y.-D., Tang, H.-Q., et al. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01895-6 · Cited by 1
“In aging human umbilical vein endothelial cells, IGFBP5 expression is upregulated, and its knockdown has been shown to partially reverse cellular aging [28].”
A geroscience approach for osteosarcopenia: Autophagy and senescence as therapeutic targets
Cordero, N. P., Schoenlein, P. V., Fulzele, S., & Hill, W. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820088-9.00031-7 · Cited by 1
Pancreatic β-Cell Senescence: A Contributor to Type 2 Diabetes
Urmi, R., Singh, R., Singh, M., & Sinha, B. K. (2025) · Springer eBooks · doi:10.1007/978-981-96-1041-9_8 · Cited by 1
Jordán, R. P. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-14852 · Cited by 1
Qu, T., Chacón, B., Faure, L., Losa, M., Hernández-Martínez, R., Robinson, K. R., Jones, A., Lisgo, S., Anda, J. D., Risolino, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.28.667310 · Cited by 1
Signaling Networks Controlling Cellular Senescence
Desai, L. P., Sanders, Y. Y., & Thannickal, V. J. (2014) · Wiley eBooks · doi:10.1002/9781118396292.ch6
Cellular stress in vitro and longevity in vivo
Dekker, P. (2012) · Leiden Repository (Leiden University)
Version of file: Published Peer Review Status: Peer reviewed Citation for item:
Wordsworth, J., & Martin-Ruiz, C. (2012)
Desai, S. J., & Li, T. (2013) · Pan Stanford Publishing eBooks · doi:10.1201/b15029-15
Woelfer, M. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7091
Expert system for LAN media selection
Johnson, M. L., Bratten, W. A., Williams, J. M. J., & Emrich, M. L. (1988) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
Rosenzweig, S. A. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735729828.793572316
Sun, Z., Wang, Z., & Zheng, X. S. (2022) · Research Square · doi:10.21203/rs.3.rs-2291800/v1
Wuestefeld, A., Iakovleva, V., Yap, S. X. L., Ong, A. B. L., Huang, D. Q., Shuen, T. W. H., Toh, H. C., Dan, Y. Y., Zender, L., & Wüestefeld, T. (2023) · doi:10.1158/0008-5472.c.6514362
Ishii, K., Hashimoto, R., Umeda, C., Hosoyama, T., & Watanabe, K. (2025) · PLoS ONE · doi:10.1371/journal.pone.0326968
Shih, A., Adelson, R. P., Vashistha, H., Khalili, H., Nayyar, A., Puran, R., Herrera, R., Chatterjee, P. K., Lee, A. T., Truskinovsky, A. M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21117839
Alessio, N., Aprile, D., Peluso, G., Mazzone, V., Patrone, D., Di Bernardo, G., & Galderisi, U. (2024) · Figshare · doi:10.6084/m9.figshare.25216796
Alessio, N., Aprile, D., Peluso, G., Mazzone, V., Patrone, D., Bernardo, G. D., & Galderisi, U. (2024) · Figshare · doi:10.6084/m9.figshare.26680358
Alessio, N., Aprile, D., Peluso, G., Mazzone, V., Patrone, D., Di Bernardo, G., & Galderisi, U. (2024) · Figshare · doi:10.6084/m9.figshare.26680355
Alessio, N., Aprile, D., Peluso, G., Mazzone, V., Patrone, D., Bernardo, G. D., & Galderisi, U. (2024) · Figshare · doi:10.6084/m9.figshare.26680352
Shih, A., Adelson, R. P., Vashistha, H., Khalili, H., Nayyar, A., Puran, R., Herrera, R., Chatterjee, P. K., Lee, A. T., Truskinovsky, A. M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21117848
Alessio, N., Aprile, D., Peluso, G., Mazzone, V., Patrone, D., Bernardo, G. D., & Galderisi, U. (2024) · Figshare · doi:10.6084/m9.figshare.25217314
Shih, A., Adelson, R. P., Vashistha, H., Khalili, H., Nayyar, A., Puran, R., Herrera, R., Chatterjee, P. K., Lee, A. T., Truskinovsky, A. M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21117851
Alessio, N., Aprile, D., Peluso, G., Mazzone, V., Patrone, D., Bernardo, G. D., & Galderisi, U. (2024) · Figshare · doi:10.6084/m9.figshare.26680349
O’Hara, S. P., Bogert, P. S. T., Dickinson, S., Chen, X., Allison, D. B., Espíndola‐Netto, J. M., Kirkland, J. L., Tchkonia, T., Ashraf, H. M., Morgenthaler, O. T., et al. (2026) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70279 · Cited by 1
Kahli, M. (2011) · theses.fr (ABES) · doi:10.70675/bc7bcb93z46bdz473aza3ebz5cc713b77897 · Cited by 1
Caractérisation de la sénescence des cardiomyocytes et identification de marqueurs associés
Maggiorani, D. (2017) · theses.fr (ABES) · doi:10.70675/a58747bczd60bz4482za3b2z7ae33d26ffa4 · Cited by 1
“Les fibroblastes sénescents présentent une augmentation de la production d’IGFBP3 (Goldstein et al., 1991) et pour les cellules endothéliales humaines (HUVEC) sénescentes, une augmentation d‘IGFBP3 et d’IGFBP5 a été observée (Kim et al., 2007a).”
BackgroundLung responses to radiation injury at the single cell level
Curras-Alonso, S. (2021) · theses.fr (ABES) · doi:10.70675/fddace61zeaf6z49a7zbc1fzb7b3ddd6f261 · Cited by 1
Insulin-like growth factor receptor signaling in physiology and disease
Dilawar, M., Malik, A., Liao, J., Shen, P., Huang, Z., Zhang, P., Wang, J., Zhang, N., Nisar, M. F., & Chen, G. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02843-w · Cited by 3
“…in lesions and interacts with ECM components (PAI-1, SPP1) to promote plaque progression through a positive feedback loop with IGF signaling, 352 whereas IGFBP6 demonstrates atheroprotective properties, and its down-regulation in atherosclerotic arteries 353 and endothelial cells…”
Nys, L., Goethals, E. R., Willer, A. S., Vandenberk, B., & Dries, E. (2026) · The Journal of Physiology · doi:10.1113/jp291160
Kojima, H., Kunimoto, H., Inoue, T., & Nakajima, K. (2013) · Springer eBooks · doi:10.1007/978-94-007-7726-2_6
Angiotensin II induced premature senescence of human vascular smooth muscle cells
Mistry, Y. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Metadata
- Authors
- Kim, K. S., Seu, Y. B., Baek, S.-H., Kim, M. J., Kim, K. J., Kim, J. H., & Kim, J.-R.
- Affiliations
- Kyungpook National University (KR)
- *Department of Biochemistry and Molecular Biology,
- Yeungnam University (KR)
- Venue
- Molecular Biology of the Cell
- Published
- 2007-11
- Volume
- 18
- Issue
- 11
- Pages
- 4543-4552
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- PMC
- PMC2043568
- OpenAlex
- W2121682401
- Cited by
- 199
- References
- 76
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 14 · 2023: 10 · 2022: 18 · 2021: 9 · 2020: 8 · 2019: 6 · 2018: 10 · 2017: 13 · 2016: 12 · 2015: 13 · 2014: 14 · 2013: 11 · 2012: 8
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Biology of the Cell (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Korea Science and Engineering Foundation (R13-2005-005-01003-0)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- IGFBP-5, cellular senescence, p53, IGF signaling pathway, premature senescence, human umbilical vein endothelial cells, atherosclerosis, intimal plaque, p16, cell proliferation
- MeSH terms
- Cell Cycle, Cells, Cultured, DNA, DNA Damage, Humans, Protein Processing, Post-Translational, Umbilical Cord, Signal Transduction, Up-Regulation, Tumor Suppressor Protein p53, Cellular Senescence, Insulin-Like Growth Factor Binding Protein 5, MicroRNAs, Endothelial Cells, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.